COMPANY ANNOUNCEMENT
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company.
Summary
- Company Announcement Date:
- FDA Publish Date:
- Product Type:
- Drugs
- Reason for Announcement:
- Recall Reason DescriptionPotential lack of sterility assurance
- Company Name:
- Greenwich
- Brand Name:
- Brand Name(s)Greenwich Rx
- Product Description:
- Product DescriptionCompounded sterile products
Company Announcement
FOR IMMEDIATE RELEASE – Tomball, Texas – November 20, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of compounded sterile products that remain within their beyond-use dates to the consumer level, including some products that were compounded by Greenwich Rx for another pharmacy, Clove Rx. For a complete list of affected products and lots, see the link below. The products are being recalled due to a potential lack of sterility assurance. These concerns arose following an inspection of the pharmacy by the FDA and Greenwich Rx’s evaluation of the affected products.
Risk Statement: Use of a drug product intended to be sterile, that is not sterile, could result in serious infections, which may be life threatening. Greenwich Rx has not identified any evidence of contamination in the recalled products; however, Greenwich Rx is initiating this recall as a precautionary measure, and you should follow all instructions below. To date, Greenwich Rx has not received any reports of adverse events related to this recall.
The affected products were dispensed nationwide between August 10, 2026 and September 21, 2026. A list of affected products, lot numbers, and beyond-use dates (expiration dates) is available at https://greenwichrx.org/news/general-recall-2026-11. Customers of Greenwich Rx and Clove Rx should compare the information on their medication labels with this list of affected products to confirm whether their medication is part of the recall.
Greenwich Rx is notifying its affected customers of this voluntary recall by mail. Customers who received medications through Clove Rx should review the affected product list, even if they have not received a direct recall notification. Greenwich Rx encourages those customers to contact Sedgwick using the information below if they have any questions about whether a product received through Clove Rx is included in the recall.
Consumers and clinics that have a product being recalled should stop use of the product immediately and discard it. Information regarding safe disposal of unused medicines is available at FDA.gov/DrugDisposal.
Customers can direct questions regarding this recall to Sedgwick at 888-243-5547 or GreenwichRx6588@sedgwick.com Monday through Friday between 8:00 AM to 5:00 PM Eastern Time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using the recalled drug products.
Adverse reactions or quality problems experienced with the use of the products may also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Company Contact Information
- Consumers:
- Sedgwick
- 888-243-5547
- Media:
- Lauren Jennings and Don Williams Glodow Nead Communications
- GreenwichRxPR@glodownead.com











